Trial NCT03419559

View at ClinicalTrials.gov 
Org. Study IDs: IOV-LUN-201

Last trial update was posted on 2019-04-16

MeSH Interventions

Durvalumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non Small Cell Lung Cancer

Stopping Reasons

The treatment landscape for NSCLC has evolved in the past year. An additional NSCLC arm will be added to the IOV-COM-202 study using TIL + pembrolizumab.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID